The CentriMag Centrifugal Blood Pump as a Benchmark for In Vitro Testing of Hemocompatibility in Implantable Ventricular Assist Devices

Artificial Organs

Volumn 39, Issue 2, 2015, Pages 93-101

  Chan, Chris H H ^a   Pieper, Ina Laura ^a   Hambly, Rebecca ^a   Radley, Gemma ^b   Jones, Alyssa ^b   Friedmann, Yasmin ^a   Hawkins, Karl M ^a   Westaby, Stephen ^b   Foster, Graham ^b   Thornton, Catherine A ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b Institute of Life Science 2   (United Kingdom)

Author keywords

Apoptosis; Cell derived microparticles; CentriMag centrifugal pump; Hemolysis; Leukocyte damage; Platelet activation; von Willebrand factor

Indexed keywords

CENTRIFUGAL PUMPS; CHEMICAL ACTIVATION; GLYCOPROTEINS; LEFT VENTRICULAR ASSIST DEVICES; PATIENT TREATMENT; PLATELETS; PROTEINS;

CELL-DERIVED MICROPARTICLE; CENTRIMAG CENTRIFUGAL PUMP; HAEMOLYSIS; LEUCOCYTE DAMAGE; LEUCOCYTES; MICRO PARTICLES; MULTIMERS; PLATELET ACTIVATION; VENTRICULAR ASSIST DEVICE; VON WILLEBRAND FACTOR;

CELL DEATH;

VON WILLEBRAND FACTOR;

APOPTOSIS; ARTICLE; BLOOD COMPATIBILITY; BLOOD PUMP; BLOOD SAMPLING; ERYTHROCYTE COUNT; HEMODYNAMICS; HEMOLYSIS; HUMAN; IN VITRO STUDY; LEUKOCYTE COUNT; LEUKOCYTE MICROPARTICLE; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PUMP DESIGN; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; ULTRAVIOLET SPECTROPHOTOMETRY; VENTRICULAR ASSIST DEVICE; ADVERSE EFFECTS; ANIMAL; BOVINE; HEART ASSIST DEVICE; LEUKOCYTE; MATERIALS TESTING; MEMBRANE MICROPARTICLE; PATHOLOGY;

BOVINAE;

ANIMALS; APOPTOSIS; CATTLE; CELL-DERIVED MICROPARTICLES; HEART-ASSIST DEVICES; HEMOLYSIS; HUMANS; LEUKOCYTES; MATERIALS TESTING; PLATELET ACTIVATION; VON WILLEBRAND FACTOR;

EID: 84922756273     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/aor.12351     Document Type: Article

References (38)

1. Westaby S, Deng M. Continuous flow blood pumps: the new gold standard for advanced heart failure? Eur J Cardiothorac Surg 2013;44:4-8.
2. Westaby S. Cardiac transplant or rotary blood pump: contemporary evidence. J Thorac Cardiovasc Surg 2013;145:24-31.
3. Kirklin JK, Naftel DC, Pagani FD, etal. Long-term mechanical circulatory support (destination therapy): on track to compete with heart transplantation? J Thorac Cardiovasc Surg 2012;144:584-603, discussion 597-8.
4. Starling RC, Moazami N, Silvestry SC, etal. Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med 2014;370:1466-1467.
5. Acker MA, Pagani FD, Stough WG, etal. Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. Circulation: Heart Failure 2013;6:e1-11.
6. Garbade J, Bittner HB, Barten MJ, Mohr F-W. Current trends in implantable left ventricular assist devices. Cardiol Res Pract 2011;2011:290516-290519.
7. Ankersmit HJ, Edwards NM, Schuster M, etal. Quantitative changes in T-cell populations after left ventricular assist device implantation: relationship to T-cell apoptosis and soluble CD95. Circulation 1999;100:II211-215.
8. Ankersmit HJ, Tugulea S, Spanier T, etal. Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Lancet 1999;354:550-555.
9. Chan CH, Hilton A, Foster G, Hawkins KM, Badiei N, Thornton CA. The evaluation of leukocytes in response to the in vitro testing of ventricular assist devices. Artif Organs 2013;37:793-801.
10. Diehl P, Aleker M, Helbing T, etal. Enhanced microparticles in ventricular assist device patients predict platelet, leukocyte and endothelial cell activation. Interact Cardiovasc Thorac Surg 2010;11:133-137.
11. Woolley JR, Teuteberg JJ, Bermudez CA, etal. Temporal leukocyte numbers and granulocyte activation in pulsatile and rotary ventricular assist device patients. Artif Organs 2013;38:447-455.
12. Klovaite J, Gustafsson F, Mortensen SA, Sander K, Nielsen LB. Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). J Am Coll Cardiol 2009;53:2162-2167.
13. Zhang JT, Gellman B, Koert A, etal. Computational and experimental evaluation of the fluid dynamics and hemocompatibility of the CentriMag blood pump. Artif Organs 2006;30:168-177.
14. Sobieski MA, Giridharan GA, Ising M, Koenig SC, Slaughter MS. Blood trauma testing of CentriMag and RotaFlow centrifugal flow devices: a pilot study. Artif Organs 2012;36:677-682.
15. ASTM. F1841-97. Standard Practice for Assessment of Hemolysis in Continuous Flow Blood Pumps. 2005.
16. ASTM. F1830-97. Standard Practice for Selection of Blood for In Vitro Evaluation of Blood Pumps. 2005.
17. Chan CH, Hilton A, Foster G, Hawkins K. Reevaluation of the Harboe assay as a standardized method of assessment for the hemolytic performance of ventricular assist devices. Artif Organs 2012;36:724-730.
18. Snyder TA, Tsukui H, Kihara S, etal. Preclinical biocompatibility assessment of the EVAHEART ventricular assist device: coating comparison and platelet activation. J Biomed Mater Res A 2007;81A:85-92.
19. Snyder TA, Watach MJ, Litwak KN, Wagner WR. Platelet activation, aggregation, and life span in calves implanted with axial flow ventricular assist devices. Ann Thorac Surg 2002;73:1933-1938.
20. Snyder TA, Litwak KN, Tsukui H, etal. Leukocyte-platelet aggregates and monocyte tissue factor expression in bovines implanted with ventricular assist devices. Artif Organs 2007;31:126-131.
21. Crow S, John R, Boyle A, etal. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg 2009;137:208-215.
22. Griffith K, Jenkins E, Stulak J, Paugh T, Pagani F. Long-term use of the CentriMag ventricular assist system as a right ventricular assist device: a case report. Perfusion 2012;27:65-70.
23. Vogler EA, Siedlecki CA. Contact activation of blood-plasma coagulation. Biomaterials 2009;30:1857-1869.
24. Geiser T, Sturzenegger M, Genewein U, Haeberli A, Beer JH. Mechanisms of cerebrovascular events as assessed by procoagulant activity, cerebral microemboli, and platelet microparticles in patients with prosthetic heart valves. Stroke 1998;29:1770-1777.
25. Slaughter MS, Rogers JG, Milano CA, etal. Advanced heart failure treated with continuous-flow left ventricular assist device. NEJM 2009;361:2241-2251.
26. Malehsa D, Meyer AL, Bara C, Struber M. Acquired von Willebrand syndrome after exchange of the HeartMate XVE to the HeartMate II ventricular assist device. Eur J Cardiothorac Surg 2009;35:1091-1093.
27. Meyer AL, Malehsa D, Bara C, etal. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device. Circulation: Heart Failure 2010;3:675-681.
28. Eckman PM. Bleeding and thrombosis in patients with continuous-flow ventricular assist devices. Circulation 2012;125:3038-3047.
29. Letsou GV, Shah N, Gregoric ID, Myers TJ, Delgado R, Frazier OH. Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. J Heart Lung Transplant 2005;24:105-109.
30. Uriel N, Pak S-W, Jorde UP, etal. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol 2010;56:1207-1213.
31. Crow S, Chen D, Milano C, etal. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. Ann Thorac Surg 2010;90:1263-1269, discussion 1269.
32. Heilmann C, Geisen U, Beyersdorf F, etal. Acquired von Willebrand syndrome in patients with ventricular assist device or total artificial heart. Thromb Haemost 2010;103:962-967.
33. Geisen U, Heilmann C, Beyersdorf F, etal. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur J Cardiothorac Surg 2008;33:679-684.
34. Pareti FI, Lattuada AL, Bressi C, etal. Proteolysis of von Willebrand factor and shear stress-induced platelet aggregation in patients with aortic valve stenosis. Circulation 2000;102:1290-1295.
35. Vincentelli A, Susen S, Le Tourneau T, etal. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 2003;349:343-349.
36. Lu Q, Hofferbert BV, Koo G, Malinauskas RA. In vitro shear stress-induced platelet activation: sensitivity of human and bovine blood. Artif Organs 2013;37:894-903.
37. Saeed D, Fukamachi K. In vivo preclinical anticoagulation regimens after implantation of ventricular assist devices. Artif Organs 2009;33:491-503.
38. Krizek DR, Rick ME. A rapid method to visualize von Willebrand factor multimers by using agarose gel electrophoresis, immunolocalization and luminographic detection. Thromb Res 2000;97:457-462.